{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T08:58:51Z","timestamp":1792313931141,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001960","name":"American Society for Radiation Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.prro.2023.04.004","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T03:57:21Z","timestamp":1682395041000},"page":"393-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO\/ESTRO Clinical Practice Guideline"],"prefix":"10.1016","volume":"13","author":[{"given":"Puneeth","family":"Iyengar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"All","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Boike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2703-0501","authenticated-orcid":false,"given":"Lisa","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Hesketh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melenda","family":"Jeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Josipovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Ruffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Senan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Widder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2023.04.004_bib0001","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.prro.2023.04.004_bib0002","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","year":"2011"},{"key":"10.1016\/j.prro.2023.04.004_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0004","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.21037\/apm-20-1409","article-title":"Oligometastatic non-small cell lung cancer: A narrative review of stereotactic ablative radiotherapy","volume":"10","author":"Dohopolski","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.prro.2023.04.004_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41571-022-00655-9","article-title":"The oligometastatic spectrum in the era of improved detection and modern systemic therapy","volume":"19","author":"Katipally","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0006","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.semradonc.2021.03.006","article-title":"Imaging and its impact on defining the oligometastatic state","volume":"31","author":"Pirasteh","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0007","doi-asserted-by":"crossref","unstructured":"Wang XS, Bai YF, Verma V, et al. Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated NSCLC [e-pub ahead of print]. J Natl Cancer Inst. 2022:djac015. https:\/\/doi.org\/10.1093\/jnci\/djac015, Epub ahead of print.","DOI":"10.1093\/jnci\/djac015"},{"key":"10.1016\/j.prro.2023.04.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0009","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0010","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2014.96","article-title":"The oligometastatic state - separating truth from wishful thinking","volume":"11","author":"Palma","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0012","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2023.04.004_bib0013","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.prro.2023.04.004_bib0014","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1245\/s10434-007-9520-7","article-title":"Laparoscopic adrenalectomy for isolated adrenal metastasis","volume":"14","author":"Strong","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0015","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0017","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/COC.0000000000000169","article-title":"Definitive stereotactic body radiotherapy (SBRT) for extracranial oligometastases: An international survey of >1000 radiation oncologists","volume":"40","author":"Lewis","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","article-title":"Radiation therapy for brain metastases: An ASTRO Clinical Practice Guideline","volume":"12","author":"Gondi","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.lungcan.2020.08.017","article-title":"European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer","volume":"150","author":"Berghmans","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0020","unstructured":"Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Available at: https:\/\/www.esmo.org\/content\/download\/347819\/6934778\/1\/ESMO-CPG-mNSCLC-15SEPT2020.pdf. Published 2020. Accessed July 13, 2022."},{"issue":"suppl 4","key":"10.1016\/j.prro.2023.04.004_bib0021","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0022","unstructured":"National Comprehensive Cancer Network (NCCN). Non-Small Cell Lung Cancer. NCCN; Version 3.2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf, Accessed March 3, 2023."},{"key":"10.1016\/j.prro.2023.04.004_bib0023","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non-small cell lung cancer-a consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0024","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/jtd.2017.02.21","article-title":"Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysis","volume":"9","author":"Li","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.prro.2023.04.004_bib0026","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/annonc\/mdu584","article-title":"A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer","volume":"26","author":"Lim","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0027","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijrobp.2015.08.012","article-title":"Three-dimensional radiation therapy to the primary tumor with concurrent chemotherapy in patients with stage IV non-small cell lung cancer: Results of a multicenter phase 2 study from PPRA-RTOG, China","volume":"93","author":"Su","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0028","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: A prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0029","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1002\/cam4.3508","article-title":"Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases","volume":"9","author":"Yamamoto","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.prro.2023.04.004_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/COC.0000000000000656","article-title":"Definitive local therapy for oligo-recurrence in patients with completely resected non-small cell lung cancer","volume":"43","author":"Matsuguma","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0031","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0032","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.21037\/jtd.2018.05.105","article-title":"Prognostic factors of oligometastatic non-small cell lung cancer: A meta-analysis","volume":"10","author":"Li","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.prro.2023.04.004_bib0033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lungcan.2018.11.017","article-title":"Addition of radiotherapy to the primary tumour in oligometastatic NSCLC: A systematic review and meta-analysis","volume":"126","author":"Petrelli","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.1007","article-title":"NRG-BR002: A phase IIR\/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and\/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557)","volume":"40","author":"Chmura","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0036","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.33546","article-title":"Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis","volume":"149","author":"Buergy","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0037","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mdu370","article-title":"Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients","volume":"25","author":"Collen","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0038","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jtho.2018.07.098","article-title":"Progression-free survival and overall survival beyond 5 years of NSCLC patients with synchronous oligometastases treated in a prospective phase II trial (NCT 01282450)","volume":"13","author":"De Ruysscher","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lungcan.2021.02.001","article-title":"A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis","volume":"154","author":"Spaggiari","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0040","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.21037\/tlcr-20-1123","article-title":"Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: A systematic review","volume":"10","author":"Bertolaccini","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.prro.2023.04.004_bib0041","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2018.06.400","article-title":"Long-term outcomes of a phase 2 trial of chemotherapy with consolidative radiation therapy for oligometastatic non-small cell lung cancer","volume":"102","author":"Petty","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0042","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jamaoncol.2019.1449","article-title":"Pembrolizumab after completion of locally ablative therapy for oligometastatic non-small cell lung cancer: A phase 2 trial","volume":"5","author":"Bauml","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0043","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lungcan.2019.02.006","article-title":"Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study","volume":"130","author":"Arrieta","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2013.07.026","article-title":"Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature","volume":"82","author":"Ashworth","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","article-title":"Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: Long-term results of a prospective phase II trial (NCT01282450)","volume":"7","author":"De Ruysscher","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0046","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.cllc.2018.09.010","article-title":"Efficacy of local consolidative therapy for oligometastatic lung adenocarcinoma patients harboring epidermal growth factor receptor mutations","volume":"20","author":"Hu","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0047","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.1634\/theoncologist.2018-0596","article-title":"M1b disease in the 8th edition of TNM Staging of Lung Cancer: Pattern of single extrathoracic metastasis and clinical outcome","volume":"24","author":"Park","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.prro.2023.04.004_bib0048","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","article-title":"A primer on interstitial lung disease and thoracic radiation","volume":"15","author":"Goodman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0049","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ijrobp.2021.08.006","article-title":"Radiation toxicity in patients with collagen vascular disease: A meta-analysis of case-control studies","volume":"111","author":"Shaikh","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaoncol.2019.5351","article-title":"Stereotactic ablative radiotherapy for the management of spinal metastases: A review","volume":"6","author":"Glicksman","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0051","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1016\/S1470-2045(17)30612-5","article-title":"An integrated multidisciplinary algorithm for the management of spinal metastases: An International Spine Oncology Consortium report","volume":"18","author":"Spratt","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0052","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/2192568217694016","article-title":"Spine stereotactic body radiotherapy: Indications, outcomes, and points of caution","volume":"7","author":"Tseng","year":"2017","journal-title":"Global Spine J"},{"key":"10.1016\/j.prro.2023.04.004_bib0053","series-title":"Paper presented at: International Association for the Study of Lung Cancer","article-title":"PL03.06 lobar or sub-lobar resection for peripheral clinical stage IA = 2 cm non-small cell lung cancer (NSCLC): Results from an international randomized phase III trial (CALGB 140503 [Alliance])","author":"Altorki","year":"2022"},{"key":"10.1016\/j.prro.2023.04.004_bib0054","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2023.04.004_bib0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.lungcan.2020.12.029","article-title":"Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study","volume":"152","author":"Blake-Cerda","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0056","first-page":"06","article-title":"A phase I trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR study)","volume":"06","author":"Bestvina","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0057","first-page":"320","article-title":"Chemotherapy combined with intermittent microwave ablation in the treatment of oligometastatic non-small cell lung cancer","volume":"26","author":"Shan","year":"2021","journal-title":"J BUON"},{"key":"10.1016\/j.prro.2023.04.004_bib0058","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0059","doi-asserted-by":"crossref","first-page":"E180","DOI":"10.1093\/neuros\/nyy548","article-title":"Congress of Neurological Surgeons systematic review and evidence-based guidelines on treatment options for adults with multiple metastatic brain tumors","volume":"84","author":"Ammirati","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.prro.2023.04.004_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/neuros\/nyx522","article-title":"Stereotactic radiosurgery in the management of limited (1-4) brain metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline","volume":"83","author":"Chao","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.prro.2023.04.004_bib0061","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1093\/neuros\/nyy541","article-title":"Congress of Neurological Surgeons systematic review and evidence-based guidelines on the role of whole brain radiation therapy in adults with newly diagnosed metastatic brain tumors","volume":"84","author":"Gaspar","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.prro.2023.04.004_bib0062","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO Guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0063","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/396592","article-title":"Oligometastatic disease at presentation or recurrence for nonsmall cell lung cancer","volume":"2012","author":"Gomez","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.prro.2023.04.004_bib0064","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctrv.2016.11.013","article-title":"Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: A systematic review","volume":"53","author":"Kroeze","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.prro.2023.04.004_bib0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12931-019-1235-3","article-title":"Analysis of key clinical features for achieving complete remission in stage III and IV non-small cell lung cancer patients","volume":"20","author":"Aoki","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.prro.2023.04.004_bib0066","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejca.2021.07.035","article-title":"Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option","volume":"156","author":"Faehling","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0067","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1186\/s12885-016-2952-3","article-title":"Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies","volume":"16","author":"Su","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195149","article-title":"Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis","volume":"13","author":"Hong","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prro.2023.04.004_bib0069","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/j.cllc.2019.06.024","article-title":"Long-term follow-up and patterns of recurrence of patients with oligometastatic NSCLC treated with pulmonary SBRT","volume":"20","author":"Horner-Rieber","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.prro.2023.04.004_bib0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2021.08.011","article-title":"An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases","volume":"164","author":"Cao","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0072","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0073","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0074","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1118\/1.2349696","article-title":"The management of respiratory motion in radiation oncology report of AAPM Task Group 76","volume":"33","author":"Keall","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0075","doi-asserted-by":"crossref","unstructured":"International Commission on Radiation Units and Measurements. J ICRU. 2014;14. https:\/\/doi.org\/10.1093\/jicru\/ndw040","DOI":"10.1093\/jicru\/ndw040"},{"key":"10.1016\/j.prro.2023.04.004_bib0076","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2022.05.035","article-title":"Planning trade-offs for SABR in patients with 4 to 10 metastases: A substudy of the SABR-COMET-10 randomized trial","volume":"114","author":"Ashram","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0077","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.prro.2016.05.004","article-title":"Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases","volume":"6","author":"Al-Hallaq","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2023.04.004_bib0078","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijrobp.2022.06.100","article-title":"Imaging-based prevalence of oligometastatic disease: A single-center cross-sectional study","volume":"114","author":"Christ","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2023.04.004_bib0079","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002300111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187985002300111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:25:28Z","timestamp":1761819928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187985002300111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S187985002300111X"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2023.04.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO\/ESTRO Clinical Practice Guideline","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2023.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}